T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo

T cells modified with chimeric antigen receptor are an attractive strategy to treat Epstein-Barr virus (EBV) associated malignancies. The EBV latent membrane protein 1 (LMP1) is a 66-KD integral membrane protein encoded by EBV that consists of transmembrane-spanning loops. Previously, we have identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xiaojun, Zhou, Yan, Li, Wenjie, Tang, Qi, Chen, Renjie, Zhu, Jin, Feng, Zhenqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250525/
https://www.ncbi.nlm.nih.gov/pubmed/25469116
http://dx.doi.org/10.7555/JBR.28.20140066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250525/
https://www.ncbi.nlm.nih.gov/pubmed/25469116
http://dx.doi.org/10.7555/JBR.28.20140066

Ejemplares similares